. India reports quality shortcomings of Chinese pharma companies | IGMPI

  • Institute of Good Manufacturing Practices India
  • Global accredited training & certification provider
  • Approved by Quality Council of India (QCI) & Accredited Vocational Institution of Ministry of HRD, Government of India
  • Approved Training Institute of Food Safety and Standards Authority of India (FSSAI)
  • Recognized by Department of Industrial Policy & Promotion, Ministry of Commerce & Industry, Government of India
  • An ISO 9001:2015 Certified Organisation registered under The Societies Registration Act,1860 Government of India
  • Empanelled under Ministry of Horticulture and Food Processing, Government of Uttar Pradesh
  • Affiliated with Life Sciences and Food Industry Sector Skills Council (SSC) set up by National Skill Development Corporation (NSDC)
  • Conferred with QUALITY COUNCIL OF INDIA (QCI) – D.L. SHAH NATIONAL QUALITY AWARD & ASSOCHAM Services Excellence Award 2017

Trusted by organizations & training participants in over 30 countries
Training | Certification | Education | Research


India reports quality shortcomings of Chinese pharma companies

In response to shortcomings Indian government has issued a showcause notices to eight Chinese pharmaceutical companies. Those companies were inspected by a special Indian inspection team and were found to supply poor quality APIs to drug manufacturers in India.

The eight Chinese companies who could be blacklisted by the Drug Controller General of India (DCGI) are:

  • M/S QiluTianhe Pharmaceuticals
  • M/S Hinan Xinxiang Pharmaceuticals,
  • M/S GuangzhaoBaiyunshan Pharmaceuticals,
  • M/S ShouguangFukang Pharmaceuticals,
  • M/S Qilu Antibiotics (Linyi) Pharmaceuticals,
  • M/S QindaoBrightmoonSeawoods and
  • M/S ShanghaoiXiandiaHasen (Shangqiu) Pharmaceuticals.

However, these companies supply a big part of the overall raw material to India. Therefore, imposing restrictions against them could result in a shortage of medicines in India. Overall, 70% of raw material comes from China, mostly due to the fact that it is four times cheaper than those produced in India. Meanwhile, the Indian government has decided to inspect APIs imported from other countries such as the United States, Italy and other European nations.